JP2018506541A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506541A5
JP2018506541A5 JP2017542062A JP2017542062A JP2018506541A5 JP 2018506541 A5 JP2018506541 A5 JP 2018506541A5 JP 2017542062 A JP2017542062 A JP 2017542062A JP 2017542062 A JP2017542062 A JP 2017542062A JP 2018506541 A5 JP2018506541 A5 JP 2018506541A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017542062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506541A (ja
JP6665193B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/050725 external-priority patent/WO2016128924A1/en
Publication of JP2018506541A publication Critical patent/JP2018506541A/ja
Publication of JP2018506541A5 publication Critical patent/JP2018506541A5/ja
Application granted granted Critical
Publication of JP6665193B2 publication Critical patent/JP6665193B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017542062A 2015-02-13 2016-02-11 Nep阻害剤を調製するための方法および中間体 Active JP6665193B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15155147.0 2015-02-13
EP15155147 2015-02-13
PCT/IB2016/050725 WO2016128924A1 (en) 2015-02-13 2016-02-11 Process and intermediates for the preparation of nep inhibitors

Publications (3)

Publication Number Publication Date
JP2018506541A JP2018506541A (ja) 2018-03-08
JP2018506541A5 true JP2018506541A5 (cg-RX-API-DMAC7.html) 2019-08-29
JP6665193B2 JP6665193B2 (ja) 2020-03-13

Family

ID=52472229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017542062A Active JP6665193B2 (ja) 2015-02-13 2016-02-11 Nep阻害剤を調製するための方法および中間体

Country Status (6)

Country Link
US (1) US10385004B2 (cg-RX-API-DMAC7.html)
EP (1) EP3256444B1 (cg-RX-API-DMAC7.html)
JP (1) JP6665193B2 (cg-RX-API-DMAC7.html)
CN (1) CN107250100B (cg-RX-API-DMAC7.html)
TW (1) TW201632493A (cg-RX-API-DMAC7.html)
WO (1) WO2016128924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3500549B1 (en) * 2016-08-17 2020-12-16 Novartis AG New processes and intermediates for nep inhibitor synthesis
CA3045954A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase
CN109053800B (zh) * 2018-07-30 2020-08-14 湖北大学 季鏻盐支载手性氨基-硫脲及其制备方法和用途
CN113121342B (zh) * 2019-12-31 2022-05-31 浙江医药股份有限公司新昌制药厂 一种沙库必曲中间体的制备方法及应用
CN114957043B (zh) * 2022-04-29 2023-09-08 凯特立斯(深圳)科技有限公司 沙库必曲中间体、其制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5439029A (en) * 1977-09-01 1979-03-24 Sagami Chem Res Center Nitro compounds
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
EP1903027A1 (en) 2006-09-13 2008-03-26 Novartis AG Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
CA2674291C (en) 2007-01-12 2015-11-24 Novartis Ag New process
AR070176A1 (es) 2008-01-17 2010-03-17 Novartis Ag Procesos de sintesis de inhibidores de nep, compuestos intermediarios y uso de los mismos en la sintesis
CN101774941A (zh) 2009-01-13 2010-07-14 浙江九洲药业股份有限公司 2-酰基氨基-3-联苯基丙酸的制备及拆分方法
ES2523734T3 (es) * 2009-05-28 2014-12-01 Novartis Ag Derivados aminopropiónicos sustituidos como inhibidores de neprilisina
EP2480523B1 (en) 2009-09-23 2017-03-01 Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Process for manufacture of n-acylbphenyl alanine
ES2550485T3 (es) 2010-01-22 2015-11-10 Novartis Ag Intermedios de inhibidores de la endopeptidasa neutra y método de preparación de los mismos
MX2013002150A (es) 2010-08-23 2013-04-03 Novartis Ag Proceso para la preparacion de intermediarios para la elaboracion de inhibidores de nep.
ES2608780T3 (es) 2010-08-23 2017-04-17 Novartis Ag Nuevo proceso para la preparación de intermediarios útiles para la elaboración de inhibidores de NEP
AR092278A1 (es) 2012-08-31 2015-04-08 Novartis Ag Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
GB201219300D0 (en) * 2012-10-26 2012-12-12 Isis Innovation Bifunctional organic catalysts
WO2015189862A1 (en) * 2014-06-10 2015-12-17 Council Of Scientific & Industrial Research Chiral amines, a process for preparation and use thereof

Similar Documents

Publication Publication Date Title
JP2018506541A5 (cg-RX-API-DMAC7.html)
JP2015506943A5 (cg-RX-API-DMAC7.html)
JP2019048806A5 (cg-RX-API-DMAC7.html)
JP2011524871A5 (cg-RX-API-DMAC7.html)
JP2018516857A (ja) アンドロゲン受容体アンタゴニストおよびその中間体の製造方法
JP2014504599A5 (cg-RX-API-DMAC7.html)
JP2007077384A5 (cg-RX-API-DMAC7.html)
JP2022116171A5 (cg-RX-API-DMAC7.html)
JP2018009003A5 (cg-RX-API-DMAC7.html)
JP2016515555A5 (cg-RX-API-DMAC7.html)
Chen et al. tert-BuOK-Catalyzed condensation of ethyl diazoacetate to aldehydes and palladium-catalyzed 1, 2-hydrogen migration for the synthesis of β-ketoesters under solvent-free conditions
JP2018505179A5 (cg-RX-API-DMAC7.html)
JP2010540414A5 (cg-RX-API-DMAC7.html)
CN108358847A (zh) 一种咪唑啉-2酮化合物的制备方法
DE602006020196D1 (de) Verfahren zur herstellung einer 3-o-alkylascorbinsäure
JP2010059146A5 (cg-RX-API-DMAC7.html)
JP2011506323A5 (cg-RX-API-DMAC7.html)
JP5452165B2 (ja) キヌクリジン類の製造法
JP2008517967A5 (cg-RX-API-DMAC7.html)
CN104710376A (zh) 一种基于炔丙酰胺的亲电碘环化反应合成噁唑啉衍生物的方法
CN105153211B (zh) 一种合成1‑(N‑Boc‑4‑哌啶)‑4‑吡唑硼酸频哪醇酯的方法
JP2016519139A (ja) デヒドロリナリルアセテートの製造方法(ii)
JP2010523620A5 (cg-RX-API-DMAC7.html)
JP2012513391A5 (cg-RX-API-DMAC7.html)
CN110294686B (zh) α-酮酰胺的绿色制备方法